OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient
Yuyi Han, Valentina Rovella, Artem Smirnov, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Yuyi Han, Valentina Rovella, Artem Smirnov, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Tumor specimen cold ischemia time impacts molecular cancer drug target discovery
Silvia von der Heyde, Nithya Raman, Nina Gabelia, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 2
Silvia von der Heyde, Nithya Raman, Nina Gabelia, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 2
Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype
Mengting Zhu, Valentina Rovella, Manuel Scimeca, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Mengting Zhu, Valentina Rovella, Manuel Scimeca, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Genetically driven predisposition leads to an unusually genomic unstable renal cell carcinoma
Manuel Scimeca, Valentina Rovella, Sabrina Caporali, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Manuel Scimeca, Valentina Rovella, Sabrina Caporali, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Molecular profiling of a bladder cancer with very high tumour mutational burden
Manuel Scimeca, Julia Bischof, Rita Bonfiglio, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Manuel Scimeca, Julia Bischof, Rita Bonfiglio, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Where Do We Stand in Targeted Therapy Against BRCA1/2 Deficient Cancers?
Zoe Manuel-Epstein
Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal (2024) Vol. 8, Iss. 8, pp. 1-11
Open Access | Times Cited: 1
Zoe Manuel-Epstein
Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal (2024) Vol. 8, Iss. 8, pp. 1-11
Open Access | Times Cited: 1
Tumour specimen cold ischemia time impacts molecular cancer drug target discovery
Silvia von der Heyde, Nithya Raman, Nina Gabelia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Silvia von der Heyde, Nithya Raman, Nina Gabelia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Unveiling the molecular profile of a prostate carcinoma: implications for personalized medicine
Massimiliano Agostini, Erica Giacobbi, Francesca Servadei, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access
Massimiliano Agostini, Erica Giacobbi, Francesca Servadei, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access
